PJP

Equity ETFs

Finding Pharmaceuticals ETFs With Rebound Potential

By Tom LydonMay 4, 2016

Equity ETFs

The Best Performing ETFs Since the Financial Downturn

By Max ChenMarch 9, 2016

Featured

Major Pharma Merger Boosts ETFs

By Tom LydonOctober 29, 2015

Featured

Political Placebo: Pharma Regulation

By Tom LydonOctober 12, 2015

Featured

A Long-Term Healthcare Winner

By Tom LydonSeptember 24, 2015

Featured

A Powerful Pharma ETF

By Tom LydonAugust 3, 2015

Featured

M&A Activity Will Support Pharma ETFs Through Rising Rate Environment

By Tom LydonJuly 9, 2015

Equity ETFs

Teva/Mylan Deal Doesn’t Stir Pharma ETFs

By Todd ShriberApril 17, 2015

Equity ETFs

Pharma ETFs Boosted by Mylan’s Giant Offer for Perrigo

By Todd ShriberApril 8, 2015

Featured

No Surprise: Healthcare ETFs See Rapid Asset Growth

By Todd ShriberMarch 19, 2015

Featured

These ETFs Might Enjoy the Salix Takeover News

By Tom LydonFebruary 23, 2015

Featured

Small Percentage of PowerShares ETFs Expected to Distribute Cap Gains

By Tom LydonDecember 15, 2014

Featured

Winning: Smart Beta ETFs Keep Gaining Traction

By Todd ShriberDecember 2, 2014

Featured

Short Covering Could be Next Catalyst for Health Care ETFs

By Todd ShriberNovember 24, 2014

Featured

The Dominance of Health Care ETFs in One Chart

By Todd ShriberNovember 20, 2014

Featured

Biotech Exposure Powers Pharma ETF to New Highs

By Todd ShriberOctober 24, 2014

Featured

Some ETFs Saying a Salix Takeover Could be Afoot

By Todd ShriberOctober 3, 2014

Featured

A Fabulous Pharma ETF

By Todd ShriberSeptember 15, 2014